Voloridge Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-20,497
| Closed | -$741K | – | 1362 |
|
2024
Q4 | $741K | Sell |
20,497
-116,964
| -85% | -$4.23M | ﹤0.01% | 1072 |
|
2024
Q3 | $4.29M | Sell |
137,461
-34,805
| -20% | -$1.09M | 0.02% | 813 |
|
2024
Q2 | $4.61M | Buy |
+172,266
| New | +$4.61M | 0.02% | 775 |
|
2024
Q1 | – | Sell |
-149,150
| Closed | -$4.32M | – | 1348 |
|
2023
Q4 | $4.32M | Buy |
149,150
+46,647
| +46% | +$1.35M | 0.02% | 658 |
|
2023
Q3 | $2.83M | Buy |
102,503
+71,744
| +233% | +$1.98M | 0.01% | 824 |
|
2023
Q2 | $925K | Buy |
+30,759
| New | +$925K | ﹤0.01% | 1134 |
|
2021
Q4 | – | Sell |
-63,894
| Closed | -$1.7M | – | 1836 |
|
2021
Q3 | $1.7M | Buy |
+63,894
| New | +$1.7M | 0.01% | 1100 |
|
2021
Q2 | – | Sell |
-57,283
| Closed | -$1.5M | – | 1780 |
|
2021
Q1 | $1.5M | Sell |
57,283
-72,885
| -56% | -$1.91M | 0.01% | 908 |
|
2020
Q4 | $3.28M | Sell |
130,168
-19,632
| -13% | -$494K | 0.03% | 574 |
|
2020
Q3 | $3.12M | Buy |
149,800
+6,799
| +5% | +$142K | 0.03% | 576 |
|
2020
Q2 | $3.4M | Buy |
143,001
+8,662
| +6% | +$206K | 0.04% | 458 |
|
2020
Q1 | $2.42M | Buy |
134,339
+63,110
| +89% | +$1.14M | 0.07% | 304 |
|
2019
Q4 | $1.69M | Buy |
71,229
+52,341
| +277% | +$1.24M | 0.03% | 527 |
|
2019
Q3 | $519K | Sell |
18,888
-14,628
| -44% | -$402K | 0.01% | 800 |
|
2019
Q2 | $1.11M | Buy |
33,516
+4,037
| +14% | +$134K | 0.03% | 439 |
|
2019
Q1 | $1.03M | Sell |
29,479
-11,363
| -28% | -$398K | 0.03% | 462 |
|
2018
Q4 | $1.36M | Buy |
+40,842
| New | +$1.36M | 0.06% | 240 |
|
2018
Q3 | – | Sell |
-33,753
| Closed | -$2.02M | – | 454 |
|
2018
Q2 | $2.02M | Buy |
+33,753
| New | +$2.02M | 0.05% | 273 |
|
2017
Q3 | – | Sell |
-29,412
| Closed | -$1.27M | – | 523 |
|
2017
Q2 | $1.27M | Buy |
+29,412
| New | +$1.27M | 0.03% | 306 |
|